Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

This is a randomized, adaptive, open label, multicenter trial to evaluate the safety and efficacy of intraperitoneal (IP) IMNN-001 plus chemotherapy compared to chemotherapy alone.

Participants needed: 500
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: ImunonUpdated: Jun 2, 2026Locations: 7
Eligibility criteria

Participants must be female, ≥18 years of age, able to understand the study proc... [+11]

Participant who has received prior treatment with IMNN-001. [+17]

Read more
Status: Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

This is a 1:1 randomized, open label, multi-center phase I/II trial to evaluate the safety, dosing, efficacy, and biological activity of adding IMNN-001 to chemotherapy + BEV compared to chemotherapy + BEV alone.

Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: ImunonUpdated: Jun 2, 2026Locations: 4
Eligibility criteria

Subjects with ovarian, fallopian tube, or primary peritoneal carcinoma with high... [+8]

Subjects who have received prior treatment with IMNN-001. [+16]

Read more